Stoke Therapeutics Inc (STOK)

Cost of Revenue

$1.14M

Quarterly · Period ending: · USD

STOK logo

STOK Cost of Revenue

Latest reported$1.14M
STOK Quarterly Cost of Revenue ($0.00 → $1.14M)
High-resolution chart · PNG

STOK cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Stoke Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
1,138,000
1,046,999
1,055,000
989,000
0
0
0
0
1,110,000
1,113,000
1,215,000
1,200,000
1,167,000
1,147,000
1,152,000
924,000
835,000
624,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.